AbbVie Newsroom

Redburn Atlantic Adjusts Price Target on AbbVie to $203 From $207

MT NewswiresJul 10 22:05

Analysts' Opinions Are Mixed on These Healthcare Stocks: Neurocrine (NBIX) and AbbVie (ABBV)

TipRanksJul 10 17:07

AbbVie (ABBV) Gets a Buy From Barclays

TipRanksJul 10 16:59

AbbVie Analyst Ratings

BenzingaJul 9 21:22

Cantor Fitzgerald Reiterates Overweight on AbbVie, Maintains $200 Price Target

BenzingaJul 9 21:22

AbbVie (ABBV) Receives a Buy From Cantor Fitzgerald

TipRanksJul 9 20:15

AbbVie Analyst Ratings

BenzingaJul 3 01:24

Piper Sandler Maintains Overweight on AbbVie, Maintains $190 Price Target

BenzingaJul 3 01:24

Buy Rating Affirmed for AbbVie on Strong Aesthetics Market Position and Positive Sales Outlook

TipRanksJul 2 09:29

Cantor Fitzgerald Reiterates Overweight on AbbVie, Maintains $200 Price Target

BenzingaJun 21 00:49

AbbVie Analyst Ratings

BenzingaJun 18 20:33

AbbVie Analyst Ratings

BenzingaJun 5 18:20

HSBC Upgrades AbbVie to Buy, Announces $185 Price Target

BenzingaJun 5 18:20

Strong Financial Outlook and Strategic Initiatives Underpin Buy Rating for AbbVie

TipRanksJun 3 09:17

Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Aerovate Therapeutics (AVTE)

TipRanksMay 22 17:55

AbbVie (ABBV.US) was first covered by Cantor Fitzgerald, which gave it an increase rating, with a target price of $200.00.

Zhitong FinanceMay 17 19:20

AbbVie Analyst Ratings

BenzingaMay 17 19:20

Buy Rating Affirmed: AbbVie's Promising Growth Trajectory and Financial Outlook

TipRanksMay 14 19:01

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

TipRanksMay 14 07:00

Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190

MT NewswiresMay 8 20:35